Related Experiment Video
Updated: May 14, 2026

Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin Analysis
Published on: February 21, 2019
Comparative Clinical Performance of Multiple-Head Skin Prick Test Devices: A Prospective Evaluation of Pain,
Marcos Sanchez-Gonzalez1, Troy Grogan2, Marvin Smollar2
1Health Services Administration, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
This study found that AllerTest devices offer superior performance in allergy testing compared to other skin prick test devices. They provide higher accuracy and consistency, reducing the risk of misinterpretation in allergen identification.
Area of Science:
- Allergy and Immunology
- Medical Device Technology
Background:
- Multiple-head skin prick test (SPT) devices are crucial for allergy diagnosis.
- Interdevice and intradevice variability in SPT devices can impact diagnostic accuracy and patient management.
- Standardization of SPT device performance is essential for reliable allergy testing.
Purpose of the Study:
- To compare the clinical performance of four FDA-cleared multiple-head SPT devices.
- To evaluate differences in pain perception, histamine sensitivity, glycerin specificity, and intradevice variability.
- To identify clinically meaningful performance variations among SPT devices.
Main Methods:
- A prospective study involving 30 healthy adults.
- Comparison of two 10-head devices (AllerTest-10, Skintestor OMNI) and two eight-head devices (AllerTest-8, Multi-Test II).
- Assessment of pain via Visual Analog Scale (VAS), histamine sensitivity (≥3 mm wheal), glycerin specificity (<3 mm wheal), and intradevice variability (coefficient of variation).
Main Results:
- All devices showed low pain scores (mean VAS 0.92-1.77) with no significant differences.
- AllerTest-10 demonstrated superior histamine sensitivity (88% vs. 68%) and lower intradevice variability (CV 0.18 vs. 0.72) compared to Skintestor OMNI.
- AllerTest-8 showed higher sensitivity (96% vs. 88%) than Multi-Test II; both AllerTest devices achieved 100% specificity.
- AllerTest devices exhibited consistently low coefficients of variation (0.18-0.19), indicating high test-head uniformity.
Conclusions:
- All evaluated SPT devices offered acceptable patient comfort and clinical performance.
- AllerTest devices showed superior clinical performance, including higher sensitivity, perfect specificity, and significantly lower intradevice variability.
- Device selection is critical for diagnostic accuracy, with lower intradevice variability enhancing reliability in allergen identification.
More Related Videos
07:10Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019